- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
-
Case Report
Rha SY, Ju SH, Shin MY, Kim JM, Joung KH, Ko YH, Kim Hj, Ku BJ
Bilateral Adrenal Lymphoma Presenting as Primary Adrenal InsufficiencyActa Endo (Buc) 2014 10(4): 693-698 doi: 10.4183/aeb.2014.693
AbstractThe incidence of primary adrenocortical insufficiency is 4.7 to 6.2 per one million. Among primary cancers developed in the adrenal gland, malignant lymphoma is very rare. We report here on an 82-year-old male patient who had primary adrenocortical insufficiency caused by bilateral adrenal lymphoma. -
Images in Endocrinology
Tausanovic KM, Zivaljevic V, Paunovic IR
Vertebral Metastasis as First Sign of Thyroid Papillary MicrocarcinomaActa Endo (Buc) 2014 10(4): 705-706 doi: 10.4183/aeb.2014.705
Abstract- -
Notes & Comments
Ursu HI
Consensus on Current Guidelines for the Management of Thyroid CancerActa Endo (Buc) 2014 10(4): 707-712 doi: 10.4183/aeb.2014.707
AbstractBritish Thyroid Association Guidelines for the management of thyroid cancer (third edition) was published recently (July 2014). The most common presentation of thyroid cancer is a newly discovered thyroid nodule or increase in size of a preexisting nodule. The long-term outcome of patients treated effectively for differentiated thyroid carcinoma is usually favorable. Nine per cent of patients with a diagnosis of thyroid cancer die of their disease. All patients with thyroid cancer should be seen within a multidisciplinary team (MDT) framework. Supra-physiological doses of levothyroxine are used to reduce the risk of thyroid cancer recurrence. The surgeon should have training and expertise in the management of thyroid cancer and be a core member of the MDT. Tumor recurrence or progression can be diagnosed earlier by detecting a raised serum thyroglobulin (Tg) after TSH stimulation (sTg) than by measurement of Tg on suppressive levothyroxine therapy. -
Actualities in medicine
Galoiu S
Clinical Trials for Reducing Cardiovascular MortalityActa Endo (Buc) 2014 10(4): 713-716 doi: 10.4183/aeb.2014.713
Abstract-